Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27517.
Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.
Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Hemophilia A and B, Liver Transplantation, Hematologic Disorder.
Sponsors: American Thrombosis and Hemostasis Network.
Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill has 2 clinical trials on record, with 1 currently active. Their work covers Hemophilia A and B, Liver Transplantation, Hematologic Disorder.
Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.